MedTrace Logo

Caudal Ropivacaine With or Without Dexmedetomidine for Post Operative Analgesia

NCT05979558 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2023-08-07

No results posted yet for this study

Summary

The goal of this clinical trial is to evaluate the postoperative analgesic effects of caudal Ropivacaine with or without Dexmedetomidine in pediatric infraumbilical surgery. The main question\[s\] it aims to answer are:

• if Caudal Dexmedetomidine with Ropivacaine would prolong the duration of analgesia in children undergoing infraumbilical surgery.

Participants will receive ropivacaine with dexmedetomidine in infraumbilical surgery.

If there is a comparison group: Investigators will compare this with ropivacaine with a placebo to see if the duration of analgesia differs.

Conditions

  • Ropivacaine
  • Infraumbilical Surgery
  • Dexmedetomidine
  • Analgesia

Interventions

DRUG

ropivacaine with dexmedetomidine

this group received with ropivacaine with dexmedetomidine

DRUG

Ropivacaine with placebo

this group received with ropivacaine with normal saline

Sponsors & Collaborators

  • National Academy of Medical Sciences, Nepal

    lead OTHER_GOV

Principal Investigators

  • Kaushal Tamang, MBBS,MD · NAMS

  • Bidur K Baral, MBBS,MD · NAMS

  • Sadichhya S Malla, MBBS,MD · Kanti Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
2 Years
Max Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-16
Primary Completion
2021-06-10
Completion
2021-12-10

Countries

  • Nepal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05979558 on ClinicalTrials.gov